Clinical Trial Update: A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing telmisartan to losartan in hypertensive patients with type 2 diabetes and overt nephropathy; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Losartan (losartan)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Diabetic Nephropathies | Phase 4 | Status: COMPLETED